Patient and public involvement
The study research question and outcome measures were developed in
collaboration with the parent representatives of the adolescents with
AIIRD, based on a shared priority to investigate the long-term immune
response to the mRNA BNT162b2 vaccine. Parents and patients with AIIRD
under the care of the medical centres conducting the trial were actively
informed regarding the study and offered enrolment. The main study
results will be disseminated to the parent representatives, who will
help in the disseminating them through parent networks locally and
abroad.